A mandate that FDA take antimicrobial breakpoint data out of drug labels and place it online could serve as the precursor for other labeling changes, including a shift of information away from paper to an electronic format.
The agency is in the process of implementing a provision in the 2016 21st Century Cures Act requiring the breakpoint...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?